The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Long-term results of a phase II trial of S-1 and cisplatin with concurrent thoracic radiotherapy for locally advanced non-small cell lung cancer.
Fumiyoshi Ohyanagi
No relevant relationships to disclose
Nobuyuki Yamamoto
No relevant relationships to disclose
Atsushi Horiike
No relevant relationships to disclose
Takeshi Horai
No relevant relationships to disclose
Takuyo Kozuka
No relevant relationships to disclose
Haruyasu Murakami
No relevant relationships to disclose
Hideyuki Harada
No relevant relationships to disclose
Toshiaki Takahashi
No relevant relationships to disclose
Yukiko Nakamura
No relevant relationships to disclose
Makoto Nishio
No relevant relationships to disclose